Back to search

Article

Rapid development and mass production of SARS-CoV-2 neutralizing Chicken egg yolk antibodies with protective efficacy in hamsters

2023-01-19

Abstract excerpt

<title>Abstract</title> <p>Despite the record speed of developing vaccines and therapeutics against the SARS-CoV-2 virus, it is not a given that such success can be secured in future pandemics. In addition, COVID-19 vaccination and application of therapeutics remain low in developing countries. Rapid and low cost mass production of antiviral IgY antibodies could be an attractive alternative or complementary optio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1a97849-a470-5f67-aabd-ca1cb947f506
DOI
10.21203/rs.3.rs-2478716/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rapid development and mass production of SARS-CoV-2 neutralizing Chicken egg yolk antibodies with protective efficacy in hamstersDOI 10.21203/rs.3.rs-2478716/v1
Norwegian Platform for Production of Antiviral Chicken Egg Yolk Immunoglobulins for Viral Pandemics PreparednessSemantic proximity
Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19Semantic proximity
Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 ReceptorSemantic proximity
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity
Edible formulations of chicken egg derived IgY antibodies neutralize SarsCoV2 Omicron RBD binding to human ACE2Semantic proximity
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceSemantic proximity
Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.Semantic proximity
Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid ProteinSemantic proximity
Fc-engineered antibody therapeutics with improved efficacy against COVID-19Semantic proximity
SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibodySemantic proximity
Avian Antibodies as Potential Therapeutic ToolsSemantic proximity
Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model.Semantic proximity
Select a neighboring publication to make it the new centre.